Cost-effectiveness of optimized background therapy plus maraviroc for previously treated patients with R5 HIV-1 infection from the perspective of the Spanish health care system

Nav

General Info

Geography

Spain (ESP)

Coverage type

Country

Time period covered

01/2009 - 12/2010

Data type

Scientific literature

Keywords

HIV and AIDS, Health care costs, Health care expenditures

Citation

Authors

Moreno S, González J, Lekander I, Martí B, Oyagüez I, Sánchez-de la Rosa R, Casado MA

Journal

Clin Ther

Volume

Issue

Pages

2232-45

Publication year

2010

Suggested citation

Moreno S, González J, Lekander I, Martí B, Oyagüez I, Sánchez-de la Rosa R, Casado MA. Cost-effectiveness of optimized background therapy plus maraviroc for previously treated patients with R5 HIV-1 infection from the perspective of the Spanish health care system. Clin Ther. 2010; 32(13): 2232-45.

DOI

10.1016/S0149-2918(10)80026-8

PMID

21316539

GHDx Entry last modified on: Apr 10, 2023

Header sites

Search form

Main menu

Cost-effectiveness of optimized background therapy plus maraviroc for previously treated patients with R5 HIV-1 infection from the perspective of the Spanish health care system

Nav